Point Prevalence of Oropharyngeal Carriage of Fluconazole‐ResistantCandidain Human Immunodeficiency Virus–Infected Patients
Open Access
- 1 October 1997
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 25 (4) , 843-846
- https://doi.org/10.1086/515554
Abstract
To estimate the prevalence of both clinically evident and asymptomatic carriage of fluconazole-resistant Candida, we prospectively surveyed 128 adultKeywords
This publication has 8 references indexed in Scilit:
- Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibilityAntimicrobial Agents and Chemotherapy, 1995
- Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transportersAntimicrobial Agents and Chemotherapy, 1995
- Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistanceThe American Journal of Medicine, 1994
- Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infectionJournal of Clinical Microbiology, 1994
- Fluconazole-resistant candidosis in an HIV cohortAIDS, 1994
- The prevalence of oral lesions in HIV-infected homosexual and bisexual menAIDS, 1991
- Mutation in cytochrome P-450-dependent 14α-demethylase results in decreased affinity for azole antifungalsBiochemical Society Transactions, 1990